Literature DB >> 2609935

An immunohistochemical study of the primitive and maturing elements of human cerebral medulloepitheliomas.

D V Caccamo1, M M Herman, L J Rubinstein.   

Abstract

Four examples of human cerebral medulloepithelioma were studied immunohistochemically with a panel of antibodies and antisera to neuronal and glial proteins. The tumors, in addition to primitive medullary epithelium, contained areas of neuroblastic, ganglionic, astrocytic, ependymoblastic and ependymal differentiation, and in one tumor, areas resembling polar spongioblastoma. Tumor cells throughout the primitive medullary epithelium displayed focal immunoreactivity for vimentin, glial fibrillary acidic (GFA) protein and for the neuron-associated class III beta-tubulin isotype. Neuroblasts showed immunoreactivity for the class III beta-tubulin isotype, microtubule-associated protein 2 and neuron-specific enolase. Immunoreactivity for neurofilament epitopes and synaptophysin was detected in areas of ganglionic differentiation and coincided with the demonstration of neurofibrils in Bielschowsky's silver impregnations. Vimentin was the only marker detected in ependymoblastic and ependymal rosettes or in areas of polar spongioblastoma, as well as in mesenchymal cells. The results indicate that, even in very primitive neoplastic neuroepithelium, immunocytochemical evidence of early commitment of some of the cells to a neuronal or glial lineage can be demonstrated. The neuron-associated class III beta-tubulin isotype appears to be one of the earliest markers indicative of neuronal differentiation in normal and neoplastic primitive neuroepithelium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2609935     DOI: 10.1007/bf00294658

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  26 in total

1.  Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors.

Authors:  M Miettinen
Journal:  Arch Pathol Lab Med       Date:  1987-09       Impact factor: 5.534

2.  Posterior fossa medulloepithelioma. Report of a case.

Authors:  P V Best
Journal:  J Neurol Sci       Date:  1974-08       Impact factor: 3.181

3.  Cerebral medulloepithelioma.

Authors:  K Jellinger
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

4.  Medulloepithelioma: definition of an entity.

Authors:  S B Karch; H Urich
Journal:  J Neuropathol Exp Neurol       Date:  1972-01       Impact factor: 3.685

5.  MAP2 is localized to the dendrites of hippocampal neurons which develop in culture.

Authors:  A Caceres; G Banker; O Steward; L Binder; M Payne
Journal:  Brain Res       Date:  1984-04       Impact factor: 3.252

6.  Cerebellar desmoplastic medulloblastomas. A further immunohistochemical characterization of the reticulin-free pale islands.

Authors:  C D Katsetos; M M Herman; A Frankfurter; P Gass; V P Collins; C C Walker; S Rosemberg; R O Barnard; L J Rubinstein
Journal:  Arch Pathol Lab Med       Date:  1989-09       Impact factor: 5.534

7.  Expression of microtubule-associated proteins, MAP-1 and MAP-2, in human neuroblastomas and differential diagnosis of immature neuroblasts.

Authors:  U Artlieb; R Krepler; G Wiche
Journal:  Lab Invest       Date:  1985-12       Impact factor: 5.662

8.  Immunohistochemical study of the early human fetal brain.

Authors:  A Sasaki; J Hirato; Y Nakazato; Y Ishida
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

9.  Expression and distribution of microtubule-associated protein 2 (MAP2) in neuroblastoma and primary neuronal cells.

Authors:  I Fischer; T B Shea; V S Sapirstein; K S Kosik
Journal:  Brain Res       Date:  1986-02       Impact factor: 3.252

10.  Ependymoblastoma: a histological, immunohistological and ultrastructural study of five cases.

Authors:  F F Cruz-Sanchez; J Haustein; M L Rossi; J Cervos-Navarro; J T Hughes
Journal:  Histopathology       Date:  1988-01       Impact factor: 5.087

View more
  4 in total

Review 1.  Curative treatment for central nervous system medulloepithelioma despite residual disease after resection. Report of two cases treated according to the GPHO Protocol HIT 2000 and review of the literature.

Authors:  Klaus Müller; Isabella Zwiener; Helmut Welker; Eberhard Maass; Rudolf Bongartz; Frank Berthold; Torsten Pietsch; Monika Warmuth-Metz; André von Bueren; Stefan Rutkowski
Journal:  Strahlenther Onkol       Date:  2011-10-28       Impact factor: 3.621

2.  Medulloepithelioma with heterologous osteoid component: a case report and review of literature.

Authors:  Yanal Omari; Ahmad A Karkash; Razan A Mansour; Nisreen Amayiri; Maisa Swaidan; Maysa Al-Hussaini
Journal:  Childs Nerv Syst       Date:  2019-01-08       Impact factor: 1.475

3.  Unusual occurrence of supratentorial medulloepithelioma in a young female.

Authors:  Andi Sadayandi Ramesh; Mahadevan Anita; Saini Jitender; Sampath Somanna
Journal:  J Neurosci Rural Pract       Date:  2014-07

4.  Human Dermal Fibroblasts Demonstrate Positive Immunostaining for Neuron- and Glia- Specific Proteins.

Authors:  C J Janmaat; K E de Rooij; H Locher; S C de Groot; J C M J de Groot; J H M Frijns; M A Huisman
Journal:  PLoS One       Date:  2015-12-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.